| Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes V Muraleedharan, H Marsh, D Kapoor, KS Channer, TH Jones European journal of endocrinology 169 (6), 725-733, 2013 | 480 | 2013 |
| Testosterone and the metabolic syndrome V Muraleedharan, TH Jones Therapeutic advances in endocrinology and metabolism 1 (5), 207-223, 2010 | 104 | 2010 |
| Testosterone and mortality V Muraleedharan, T Hugh Jones Clinical endocrinology 81 (4), 477-487, 2014 | 96 | 2014 |
| Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice DM Kelly, JE Nettleship, S Akhtar, V Muraleedharan, DJ Sellers, ... Life sciences 109 (2), 95-103, 2014 | 96 | 2014 |
| Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse DM Kelly, S Akhtar, DJ Sellers, V Muraleedharan, KS Channer, TH Jones Endocrine 54, 504-515, 2016 | 86 | 2016 |
| Testosterone deficiency and severity of erectile dysfunction are independently associated with reduced quality of life in men with type 2 diabetes JC Brooke, DJ Walter, D Kapoor, H Marsh, V Muraleedharan, TH Jones Andrology 2 (2), 205-211, 2014 | 44 | 2014 |
| Low testosterone predicts increased mortality and testosterone replacement therapy improves survival in men with type 2 diabetes V Muraleedharan, H Marsh, H Jones Endocrine Abstracts 25, 2011 | 7 | 2011 |
| Pharmacotherapy of type 2 diabetes mellitus in frail elderly patients A Sathyanarayanan, A Rabindranathnambi, V Muraleedharan British Journal of Hospital Medicine 80 (11), C162-C165, 2019 | 3 | 2019 |
| Long-term testosterone replacement improves survival in men with type 2 diabetes and hypogonadism endocr rev V Muraleedharan, H Marsh, KS Channer, HT Jones Endocr Rev 32, OR35-2, 2011 | 3 | 2011 |
| The Effect of Testosterone Undecanoate on Cardiovascular Risk Factors in Men with Hypogonadism in Clinical Practice. V Muraleedharan, N Ranjan, C Rolfe, TH Jones Endocrine Reviews 31 (3), 2010 | 3 | 2010 |
| Hormonersatztherapie des Mannes M Zitzmann DMW-Deutsche Medizinische Wochenschrift 143 (19), 1405-1416, 2018 | 2 | 2018 |
| Testosterone replacement therapy has beneficial effects on cardiovascular risk factors and liver function in hypogonadal men J Brooke, D Walter, V Muraleedharan, TH Jones Endocrine Abstracts 28, 2012 | 2 | 2012 |
| Low testosterone level is associated with significant increase in mortality in patients with type 2 diabetes V Muraleedharan, H Marsh, H Jones Endocrine Abstracts 21, 2010 | 2 | 2010 |
| The diabetes NSF: are targets being met 5 years on V Muraleedharan, PD Shanmugarajah, T Dodd, L Caddick, C Hardisty, ... Diabet Med 23 (Suppl 2), P293, 2006 | 2 | 2006 |
| Monitoring thyroid function during amiodarone use P Sharma, R Sheikh, N Siribaddana, A Sathyanarayanan, D Fernando, ... British Journal of Hospital Medicine 85 (1), 1-5, 2024 | 1 | 2024 |
| Testosterone differentially regulates liver X receptor expression and targets of lipid and glucose metabolism in liver, muscle and adipose tissue of the testicular feminised mouse D Kelly, S Akhtar, V Muraleedharan, J Brooke, D McLaren, K Channer, ... Endocrine Abstracts 32, 2013 | 1 | 2013 |
| Testosterone undecanoate has a beneficial effect on lipid profile in men with hypogonadism in routine clinical practice V Muraleedharan, C Rolfe, N Ranjan, H Jones Endocrine Abstracts 25, 2011 | 1 | 2011 |
| Acute Visual Loss Due to PDE5 Inhibitor Induced Non Arteritic Anterior Ischaemic Optic Neuropathy in a Young Man with Hypogonadism and Erectile Dysfunction. V Muraleedharan, TH Jones, HMJ Hassan ENDOCRINE REVIEWS 31 (3), 2010 | 1 | 2010 |
| Testosterone replacement may be beneficial in hypogonadal men with cardiovascular disease V Muraleedharan, C Dugdale, R Stanworth, H Jones Endocrine Abstracts 21, 2010 | 1 | 2010 |
| Treat to target? Efficacy of insulin use in patients with type 2 diabetes (T2DM) in a secondary care setting V Muraleedharan, L Caddick, C Hardisty, S Tesfaye, A Scott DIABETIC MEDICINE 24, 75-75, 2007 | 1 | 2007 |
